23 May 2013
Keywords: roche, halts, ph, ii, trial, anemia, drug
Article | 05 March 2007
Swiss drug major Roche is temporarily suspending recruitment in a Phase II trial of its continuous erythropoietin receptor activator Micera,
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 March 2007
© 2013 thepharmaletter.com